Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000231195 | SCV000291594 | likely benign | Hypercholesterolemia, autosomal dominant, 3 | 2023-11-15 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000584609 | SCV000690956 | likely benign | Hypercholesterolemia, familial, 1 | 2017-11-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002327147 | SCV002633029 | likely benign | Cardiovascular phenotype | 2020-11-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV000231195 | SCV002797380 | likely benign | Hypercholesterolemia, autosomal dominant, 3 | 2021-07-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003326383 | SCV004032952 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | PCSK9: BP4, BP7 |
All of Us Research Program, |
RCV000231195 | SCV004836574 | likely benign | Hypercholesterolemia, autosomal dominant, 3 | 2024-01-11 | criteria provided, single submitter | clinical testing | |
GENin |
RCV004820009 | SCV005441508 | likely benign | Familial hypercholesterolemia | 2023-07-07 | criteria provided, single submitter | clinical testing | This is a synonymous (silent) variant that is not predicted by SpliceAI to impact splicing. In addition, it occurs at a nucleotide that is not conserved. Therefore this variant has been classified as Likely Benign (BP4, BP7). |